Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
Review paper
Non-alcoholic fatty liver disease and lipotoxicity
Natalia Wasilewska,
Dariusz Marek Lebensztejn
Clin Exp HEPATOL 2021; 7, 1: 1-6
Online publish date: 2021-03-25
Original paper
Should patients with unresectable gallbladder cancer with hilar involvement undergo unilateral or bilateral percutaneous biliary drainage in the setting of cholangitis?
Pankaj Gupta,
Varun Bansal,
Naveen Kalra,
Jayanta Samanta,
Harshal Mandavdhare,
Vishal Sharma,
Usha Dutta,
Rakesh Kochhar,
Manavjit Singh Sandhu
Clin Exp HEPATOL 2021; 7, 1: 7-12
Online publish date: 2021-03-25
Original paper
Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy
Michał Kukla,
Rafał Kierach,
Magdalena Skonieczna,
Dorota Hudy,
Krzysztof Dąbrowski,
Tomasz Menżyk,
Aleksandra Derra,
Dariusz Boroń,
Beniamin Oskar Grabarek
Clin Exp HEPATOL 2021; 7, 1: 13-24
Online publish date: 2021-03-25
Original paper
The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis
Anas Renno,
Yousef Abdel-Aziz,
Yaseen Alastal,
Sadik Khuder,
Syed Hasan,
Ragheb Assaly,
Ali Nawras
Clin Exp HEPATOL 2021; 7, 1: 25-29
Online publish date: 2021-03-25
Original paper
Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters
Narges Abdoli,
Issa Sadeghian,
Negar Azarpira,
Mohammad Mehdi Ommati,
Reza Heidari
Clin Exp HEPATOL 2021; 7, 1: 30-40
Online publish date: 2021-03-25
Original paper
The usefulness of immunohistochemical staining of bile tracts in biliary atresia
Joanna Cielecka-Kuszyk,
Maria Janowska,
Małgorzata Markiewicz,
Piotr Czubkowski,
Anna Ostoja-Chyżyńska,
Joanna Beata Bierła,
Bożena Cukrowska,
Joanna Pawłowska
Clin Exp HEPATOL 2021; 7, 1: 41-46
Online publish date: 2021-03-25
Original paper
Predictors of azathioprine toxicity in children with autoimmune hepatitis
Behairy El-Sayed Behairy,
Hala Hany El-Said,
Hatem Abd-Alsattar Konswa,
Ahmed El-Sayed Nour El-Deen,
Nermin Mohamed Adawy,
Ahmad Mohamed Sira
Clin Exp HEPATOL 2021; 7, 1: 47-54
Online publish date: 2021-03-25
Original paper
Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease
Caridad Ruenes Domech,
Julio Cesar Fernandez Travieso,
Zaily Dorta Guridi,
Marlen Ivón Castellanos Fernández,
Sacha Lazo del Vallín,
Anaisa Rojas Carralero,
Elena Ferrer Batallie,
Aimeé Marcia Alvarez Alvarez,
Lilia Fernández Dorta,
José Illnait Ferrer,
Sarahi Mendoza Castaño,
Maytee Robaina García,
Gladys Jiménez Rivero,
Yeni Veliz Alvarez
Clin Exp HEPATOL 2021; 7, 1: 55-65
Online publish date: 2021-03-12
Original paper
Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study
Ahmed Kamal,
Amr Aly Abd Elmoety,
Yousri Abdelmeguid Rostom,
Mohamed Said Shater,
Sameh Aldesoky Lashen
Clin Exp HEPATOL 2021; 7, 1: 66-73
Online publish date: 2021-03-11
Original paper
Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development
Eman Saad Nassar,
Yomna Abdelrazek Elkalbashawy,
Ahmed Kamal,
Nermine Hossam Eldin Zakaria
Clin Exp HEPATOL 2021; 7, 1: 74-78
Online publish date: 2021-03-15
Original paper
Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
Tadeusz Wojciech Łapiński,
Aleksandr Tarasik,
Marcin Januszkiewicz,
Robert Flisiak
Clin Exp HEPATOL 2021; 7, 1: 79-84
Online publish date: 2021-03-25
Original paper
Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients
Aymen Farid Elshayeb,
Mohamed Gamal Abdrabu,
Sara Lotfy Asar,
Mohamed Adel Abdelaziz,
Hossam Abuelkheir
Clin Exp HEPATOL 2021; 7, 1: 85-92
Online publish date: 2021-03-25
Original paper
Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C
Dorota Orzechowska,
Katarzyna Klimowicz,
Anna Stępień,
Tomasz Mikuła,
Mariusz Sapuła,
Alicja Wiercińska-Drapało
Clin Exp HEPATOL 2021; 7, 1: 93-100
Online publish date: 2021-03-15
Original paper
Characterization of CD326-positive human hepatic stem cells
Eva Schmelzer,
Giada Pietrosi,
Bruno Gridelli,
Jörg Gerlach
Clin Exp HEPATOL 2021; 7, 1: 101-110
Online publish date: 2021-03-15
Original paper
FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study
Roberto Catanzaro,
Alice Aleo,
Morena Sciuto,
Luca Zanoli,
Baskar Balakrishnan,
Francesco Marotta
Clin Exp HEPATOL 2021; 7, 1: 111-116
Online publish date: 2021-03-25
Original paper
Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy
Agnieszka Stawicka,
Magdalena Świderska,
Justyna Zbrzeźniak,
Natalia Sołowianowicz,
Aleksandra Woszczenko,
Robert Flisiak,
Jerzy Jaroszewicz
Clin Exp HEPATOL 2021; 7, 1: 117-124
Online publish date: 2021-02-02
|